Free Trial
Notice: This company has been marked as potentially delisted and may not be actively trading.
NYSE:HRC

Hill-Rom (HRC) Stock Price, News & Analysis

Hill-Rom logo

About Hill-Rom Stock (NYSE:HRC)

Key Stats

Today's Range
$155.96
$155.96
50-Day Range
$155.05
$156.18
52-Week Range
$93.34
$156.22
Volume
N/A
Average Volume
656,912 shs
Market Capitalization
$10.30 billion
P/E Ratio
41.92
Dividend Yield
0.62%
Price Target
N/A
Consensus Rating
N/A

Company Overview

Hill-Rom Holdings, Inc. operates as a medical technology company. The firm focuses on patient care solutions that improve clinical and economic outcomes. It operates through the following segments: Patient Support System, Front Line Care and Surgical Solutions. The Patient Support Systems segment provides bed frames and surfaces, mobility and clinical workflow solutions. The Front Line Care segment offers respiratory care products and sells medical diagnostic equipment and a diversified portfolio of devices. The Surgical Solutions segment supplies surgical products including tables, lights, pendants, positioning devices, various other surgical products and accessories. The company was founded by William A. Hillenbrand on August 7, 1969 and is headquartered in Chicago, IL.

Receive HRC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Hill-Rom and its competitors with MarketBeat's FREE daily newsletter.

HRC Stock News Headlines

Why I'm telling friends to avoid gold stocks
Back in November, gold made a tiny move of 1.6%. But according to my backtesting by using a special type of gold trade, I would have seen a 141% gain in just a week. It happened again in March. Gold nudged up 1.2%. This time? A 104% overnight gain. And in June? A 1% gold move turned into a 74% gain in two weeks. Granted, there would have been smaller wins and those that did not work out, but you see, there's a reason I'm telling all my friends to hold off from buying gold or regular gold stocks right now. There's a more lucrative way to play the gold market as we enter a new breakout period. It's all about catching what I call "Acceleration Cycles."
Here Are The Best 37 Rom-Coms Ever Made
See More Headlines

HRC Stock Analysis - Frequently Asked Questions

Hill-Rom Holdings, Inc. (NYSE:HRC) released its quarterly earnings results on Friday, November, 5th. The medical technology company reported $1.67 earnings per share for the quarter, beating analysts' consensus estimates of $1.47 by $0.20. The business's revenue was up 13.1% on a year-over-year basis.

Hill-Rom subsidiaries include these companies: Breathe Technologies, Voalte Inc, Mortara Instrument, Tridien Medical, Trumpf Medical Systems Ltd., Welch Allyn Inc., Virtus Inc., and others.

Based on aggregate information from My MarketBeat watchlists, some other companies that Hill-Rom investors own include Steel Dynamics (STLD), Walt Disney (DIS), NVIDIA (NVDA), PayPal (PYPL), Block (SQ), Meta Platforms (META) and Bank of America (BAC).

Company Calendar

Last Earnings
11/05/2021
Today
12/25/2024
Fiscal Year End
9/30/2025

Industry, Sector and Symbol

Sector
Medical
Industry
Surgical & Medical Instruments
Sub-Industry
Health Care Equipment
CUSIP
43147510
Employees
10,000
Year Founded
1929

Profitability

Net Income
$248.50 million
Pretax Margin
10.03%

Debt

Sales & Book Value

Annual Sales
$3.02 billion
Cash Flow
$9.29 per share
Book Value
$28.56 per share

Miscellaneous

Free Float
65,594,000
Market Cap
$10.30 billion
Optionable
Optionable
Beta
0.55

Social Links

10 Best Stocks to Own in 2025 Cover

Click the link below and we'll send you MarketBeat's list of the 10 best stocks to own in 2025 and why they should be in your portfolio.

Get This Free Report

This page (NYSE:HRC) was last updated on 12/25/2024 by MarketBeat.com Staff
From Our Partners